Maui Derm NP + PA 2024 | Fall Conference Preview
HCPLive
SEPTEMBER 14, 2024
This is an overview of our upcoming Maui Derm NP+PA Fall 2024 Program conference coverage.
Sat.Sep 14, 2024
69 
Diagnosis of congenital heart disease in adulthood: How often, how relevant?
The American Journal of Cardiology
SEPTEMBER 14, 2024
Publication date: Available online 13 September 2024 Source: The American Journal of Cardiology Author(s): Elisabet Viera, Pablo Meras, Carlos Merino, Eliu Perez, Jose Ruiz, Enrique Balbacid, Cesar Abelleira, Angel Aroca, Raul Moreno
Nutrition’s Role in MASH, Cirrhosis Management, with Tessa Janovsky, PA-C
HCPLive
SEPTEMBER 14, 2024
Janovsky explains the importance of nutrition and dietary interventions in MASH and cirrhosis management, reviewing how providers can discuss both with patients.
Long-term outcomes of left bundle branch area pacing compared with right ventricular pacing in TAVI patients
HeartRhythm
SEPTEMBER 14, 2024
New-onset permanent pacemaker implantation (PPMI) is still a common complication after transcatheter aortic valve implantation (TAVI) with adverse clinical outcomes.
Bridging Innovation & Patient Care: The Growing Role of AI
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Andrea Banty, NP, DNP: Navigating New Developments in IBD Therapeutics
HCPLive
SEPTEMBER 14, 2024
Banty discusses recent advancements in the ulcerative colitis and Crohn disease treatment landscapes, explaining how to navigate the growing number of treatment options.
Validation of Novel Risk Prediction Models in Patients with Brugada Syndrome: A Multicenter Study in Japan
HeartRhythm
SEPTEMBER 14, 2024
Risk stratification in patients with Brugada syndrome (BrS) is challenging, especially in those at intermediate risk. The Predicting Arrhythmic evenT (PAT) score has recently been demonstrated to be excellent for predicting future arrhythmic events in patients without prior ventricular fibrillation (VF). However, validation studies are lacking.
Let's personalize your content